Response assessed by Ultrasonography as Target of Biological Treatment for Crohn's disease: Treat to target in CD using Ultrasonography.

[1]  N. Caporaso,et al.  One‐year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing , 2019, Alimentary pharmacology & therapeutics.

[2]  J. Stoker,et al.  ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. , 2018, Journal of Crohn's & colitis.

[3]  J. Stoker,et al.  ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. , 2018, Journal of Crohn's & colitis.

[4]  A. Griffiths,et al.  Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn's Disease , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  W. Sandborn,et al.  Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. , 2018, Gastroenterology.

[6]  Annmarie Lassen,et al.  Feasibility and Diagnostic Accuracy of Point‐of‐Care Abdominal Sonography by Pocket‐Sized Imaging Devices, Performed by Medical Residents , 2017, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[7]  N. Caporaso,et al.  Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[8]  J. Maul,et al.  Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  H. Tilg,et al.  3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management , 2017, Journal of Crohn's & colitis.

[10]  J. Rimola,et al.  Ultrasonographic Changes at 12 Weeks of Anti-TNF Drugs Predict 1-year Sonographic Response and Clinical Outcome in Crohn's Disease: A Multicenter Study , 2016, Inflammatory bowel diseases.

[11]  J. Fletcher,et al.  Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease , 2016, The American Journal of Gastroenterology.

[12]  S. Hanauer,et al.  Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts , 2016, Inflammatory bowel diseases.

[13]  D. Tanyingoh,et al.  Clinic-based Point of Care Transabdominal Ultrasound for Monitoring Crohn's Disease: Impact on Clinical Decision Making. , 2015, Journal of Crohn's & colitis.

[14]  T. Murdoch,et al.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target , 2015, The American Journal of Gastroenterology.

[15]  E. Calabrese,et al.  Positioning Ultrasonography Into Clinical Practice for the Management of Crohn's Disease. , 2015, Gastroenterology & hepatology.

[16]  Steven J Brown,et al.  Crohn's disease management after intestinal resection: a randomised trial , 2015, The Lancet.

[17]  L. Biancone,et al.  A sonographic lesion index for Crohn's disease helps monitor changes in transmural bowel damage during therapy. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  N. Moreno,et al.  Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: changes following treatment with immunomodulators and/or anti-TNF antibodies. , 2014, Journal of Crohn's & colitis.

[19]  A. Amiot,et al.  European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[20]  N. Caporaso,et al.  Transmural Healing Evaluated by Bowel Sonography in Patients with Crohn’s Disease on Maintenance Treatment with Biologics , 2013, Inflammatory bowel diseases.

[21]  G. Simonetti,et al.  Accuracy of small-intestine contrast ultrasonography, compared with computed tomography enteroclysis, in characterizing lesions in patients with Crohn's disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  M. Neurath,et al.  Mucosal healing in inflammatory bowel diseases: a systematic review , 2012, Gut.

[23]  B. Ciccantelli,et al.  Small intestine contrast ultrasonography (SICUS) for the detection of small bowel complications in crohn's disease: A prospective comparative study versus intraoperative findings , 2010, Inflammatory bowel diseases.

[24]  P. Rutgeerts,et al.  Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. , 2011, Gastroenterology.

[25]  J. Fletcher,et al.  Computed tomography enterography detects intestinal wall changes and effects of treatment in patients with Crohn's disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  P. Rutgeerts,et al.  Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. , 2010, Gastroenterology.

[27]  T. Ripollés,et al.  Abdominal Sonographic Changes After Antibody to Tumor Necrosis Factor (Anti-TNF) Alpha Therapy in Crohn’s Disease , 2010, Digestive Diseases and Sciences.

[28]  L. Biancone,et al.  Severity of postoperative recurrence in crohn's disease: Correlation between endoscopic and sonographic findings , 2009, Inflammatory bowel diseases.

[29]  P. Rutgeerts,et al.  Mucosal healing predicts long‐term outcome of maintenance therapy with infliximab in Crohn's disease , 2009, Inflammatory bowel diseases.

[30]  M. Vos,et al.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial , 2008, The Lancet.

[31]  M. Bala,et al.  Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease , 2006 .

[32]  R. Caprilli,et al.  Small Intestine Contrast Ultrasonography: An Alternative to Radiology in the Assessment of Small Bowel Disease , 2005, Inflammatory bowel diseases.

[33]  E. Corazziari,et al.  Crohn's Disease: A Comparative Prospective Study of Transabdominal Ultrasonography, Small Intestine Contrast Ultrasonography, and Small Bowel Enema , 2005, Inflammatory bowel diseases.

[34]  S. Gallus,et al.  Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy , 2004, Gut.

[35]  E. Corazziari,et al.  Ultrasonography of the small bowel after oral administration of anechoic contrast solution , 1999, The Lancet.

[36]  J. Meléndez,et al.  Anxiety-related reactions associated with magnetic resonance imaging examinations. , 1993, JAMA.